DSIP (Delta Sleep‑Inducing Peptide) is a research‑grade neuropeptide examined in scientific settings for its role in neuroendocrine signaling, stress‑response pathways, and circadian‑related biochemical processes. Current research interest focuses on DSIP’s interactions with central nervous system peptides, its potential influence on hypothalamic activity, and its behavior in mechanistic and model‑based studies.

In the Canatide catalog, DSIP is supplied as a high‑purity peptide intended exclusively for controlled laboratory experimentation, including in‑vitro assays, receptor‑binding studies, stability analysis, and pathway mapping. No clinical, therapeutic, or performance outcomes are evaluated or implied.